Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Chi-Yuan Wu

1PUBLICATIONS

11CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Mar 22, 2024

Clinical dose rationale of tislelizumab in patients with solid or hematological advanced tumors.

Tian Yu, Xiangyu Liu, Chi-Yuan Wu

Pageof 1

Frequent Collaborators

1 joint publications

Tian Yu

1 joint publications

Xiangyu Liu

1 joint publications

Zhiyu Tang

1 joint publications

Hongwei Wang

1 joint publications

Patrick Schnell

1 joint publications

Ya Wan

1 joint publications

Kun Wang

1 joint publications

Lucy Liu

1 joint publications

Yuying Gao

1 joint publications

Srikumar Sahasranaman

Frequent Collaborators

1 joint publications

Tian Yu

1 joint publications

Xiangyu Liu

1 joint publications

Zhiyu Tang

1 joint publications

Hongwei Wang

Top Related Videos

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on : Jan 29, 2019

See more related videos

Top Related Videos

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on : Jan 29, 2019

See more related videos